Earnings History Data for Adverum Biotechnologies (ADVM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Adverum Biotechnologies

Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum?s core capabilities include clinical development, novel vector discovery and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
18-03-2024	AH		ADVM	Adverum Biotechnologies	358.00	-0.23	-0.28	0.00	Adverum Biotechnologies GAAP EPS of -$0.23 beats by $0.11 [3/18/2024 4:35 PM]	1.63	-0.14 (-7.91%)	1.68	-0.09 (-5.08%)	0.68 - 2.97	3,265,218	2,000,000	11,032
Adverum Biotechnologies GAAP EPS of -$0.23 beats by $0.11 [3/18/2024 4:35 PM]
30-03-2023	PM		ADVM	Adverum Biotechnologies	80.00	-0.33	-0.32	0.00	Adverum Biotechnologies GAAP EPS of -$0.33 beats by $0.03 [3/31/2023 12:36 AM]	0.7199	0.0 (-0.01%)	0.77	0.05 (6.94%)	0.53 - 1.82	90,847	720,000	2,066
Adverum Biotechnologies GAAP EPS of -$0.33 beats by $0.03 [3/31/2023 12:36 AM]
29-03-2022	AH	4:05 PM ET (Mar 29)	ADVM	Adverum Biotechnologies, Inc.	137.41	-0.35	-0.42	-0.39	Adverum Biotechnologies GAAP EPS of -$0.35 misses by $0.01 [3/29/2022 4:49 PM]	1.34	-0.04 (-3.24%)	1.39	0.0 (0.00%)	1.21 - 10.85	526,035	2,010,000	1,400
Adverum Biotechnologies GAAP EPS of -$0.35 misses by $0.01 [3/29/2022 4:49 PM] Adverum Biotechnologies Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-29-22 04:05PM]
05-08-2021	AH	4:00 PM ET (Aug 5)	ADVM	Adverum Biotechnologies, Inc.	231.00	-0.45	-0.37	0.00	Adverum Biotechnologies EPS misses by $0.07 [8/5/2021 5:25 PM]	2.48	0.07 (2.90%)	2.36	-0.05 (-2.07%)	2.23 - 19.25	1,908,386	3,170,000	25,225
Adverum Reports Second Quarter 2021 Results [Aug-05-21 04:05PM] Why Adverum Biotechnologies (ADVM) Might Surprise This Earnings Season [Aug-06-21 10:19AM]
01-03-2021	AH	4:00 PM ET (Mar 1)	ADVM	Adverum Biotechnologies, Inc.	1,250	-0.39	-0.32	-0.29	Adverum Biotechnologies EPS misses by $0.06 [3/1/2021 4:06 PM]	12.29	-1.03 (-7.73%)	13.25	-0.07 (-0.53%)	7.36 - 26.98	547,251	749,925	1,028
Adverum Biotechnologies EPS misses by $0.06 [3/1/2021 4:06 PM] Adverum Biotechnologies, Inc. (ADVM) Q4 2020 Earnings Call Transcript [Mar-02-21 07:31AM] Adverum Biotechnologies (ADVM) Reports Q4 Loss, Misses Revenue Estimates [Mar-01-21 05:25PM]
05-11-2020	AH		ADVM	Adverum Biotechnologies, Inc.	1,180	-0.31	-0.35	-0.25	Adverum Biotechnologies EPS beats by $0.04, beats on revenue [11/5/2020 5:18 PM]	12.05	-0.13 (-1.07%)	12.18	0.0 (0.00%)	7.15 - 26.98	497,691	837,892	100

10-08-2020	AH	4:00 PM ET (Aug 10)	ADVM	Adverum Biotechnologies, Inc.	1,430	-0.36	-0.30	-0.23	Adverum Biotechnologies EPS misses by $0.06, beats on revenue [8/10/2020 4:09 PM]	16.75	-1.95 (-10.43%)	19.00	0.30 (1.60%)	4.96 - 26.98	991,114	702,921	2,028

28-05-2020	AH	4:00 PM ET (May 28)	ADVM	Adverum Biotechnologies, Inc.	1,640	-0.31	-0.27	-0.23	Adverum Biotechnologies EPS misses by $0.04 [5/28/2020 4:11 PM]	17.97	-2.35 (-11.56%)	19.88	-0.44 (-2.17%)	4.96 - 23.79	868,899	934,250	379